Related Experiment Video
Updated: Jan 20, 2026

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
Published on: June 15, 2018
Clostridium difficile Toxin A Upregulates Bak Expression through PGE2 Pathway in Human Colonocytes
1Division of Life Science and Chemistry, College of Natural Science, Daejin University, Pocheon, Gyeonggido, 487-711, Republic of Korea.
Clostridium difficile toxin A induces colon cell death by increasing Bak protein expression, a process mediated by prostaglandin E2 (PGE2) via the EP1 receptor, leading to inflammation.
Area of Science:
- Gastroenterology
- Cell Biology
- Molecular Biology
Background:
- Clostridium difficile toxin A causes colonocyte apoptosis, initiating inflammation.
- Epithelial barrier dysfunction is a key consequence of toxin A exposure.
- Prostaglandin E2 (PGE2) mediates toxin A-induced apoptosis and inflammation, but the mechanism is unclear.
Purpose of the Study:
- To elucidate the molecular signaling pathway of PGE2-mediated colonocyte apoptosis induced by C. difficile toxin A.
- To identify the specific receptor and downstream molecules involved in this process.
Main Methods:
- Exposure of NCM460 human colonocytes to C. difficile toxin A.
- RT-PCR analysis to assess gene expression changes, specifically for Bak.
- Treatment with EP receptor agonists to investigate the role of specific prostaglandin receptors.
Main Results:
- Toxin A significantly upregulated Bak expression in colonocytes, a pro-apoptotic protein.
- This Bak upregulation was transcriptionally mediated and dependent on PGE2 production.
- The effect of toxin A was mimicked by an EP1 receptor agonist, but not other EP receptor agonists.
Conclusions:
- Toxin A-induced colonocyte apoptosis involves the upregulation of Bak.
- This process is mediated by PGE2 signaling through the EP1 receptor.
- The findings clarify a key mechanism in C. difficile-associated gut inflammation.
Related Concept Videos
09:12A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
06:51Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
11:13Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
12:58A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
09:53A Purification and In Vitro Activity Assay for a (p)ppGpp Synthetase from Clostridium difficile
09:13Development of a Larval Zebrafish Infection Model for Clostridioides difficile

